Eli Lilly’s obesity drug beats rival in head-to-head trial – where Cramer sees stocks move next
New trial data has solidified the Club's lead position, holding off Eli Lilly in the highly competitive obesity drug race. ...
New trial data has solidified the Club's lead position, holding off Eli Lilly in the highly competitive obesity drug race. ...
An Eli Lilly & Co. Zepbound injector pen displayed in the Brooklyn borough of New York, United States, on Thursday, ...